CORNERSTONE THERAPEUTICS INC Uncategorized Contracts & Agreements
45 Contracts & Agreements
- Chiesi Farmaceutici S.p.A. Via Palermo 26/1 43122 Parma, Italy (Filed With SEC on May 17, 2012)
- EX-101 INSTANCE DOCUMENT (Filed With SEC on August 4, 2011)
- Current assets (Filed With SEC on May 12, 2011)
- Current assets (Filed With SEC on November 4, 2010)
- Current assets (Filed With SEC on November 4, 2010)
- Current assets (Filed With SEC on November 4, 2010)
- Current assets (Filed With SEC on August 5, 2010)
- Current assets (Filed With SEC on August 5, 2010)
- Current assets (Filed With SEC on August 5, 2010)
- Current assets (Filed With SEC on May 4, 2010)
- Current assets (Filed With SEC on May 4, 2010)
- Ex-10.2 Amendment to Stockholders Agreement (Filed With SEC on June 29, 2009)
- EX-10.4 Stockholders Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)
- EX-10.3 Governance Agreement, dated as of May 6, 2009 (Filed With SEC on May 12, 2009)
- Ex-10.51 Letter from Paragon Commercial Bank to Cornerstone BioPharma Holdings, Inc. dated October 29, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.45 Letter Agreement, dated June 23, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.9 Formulation Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated January 11, 2008 (Filed With SEC on November 5, 2008)
- Ex-10.8 Letter Agreement between Meiji Seika Kaisha, Ltd. and Cornerstone BioPharma, Inc. dated July 27, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.5 Manufacturing Agreement between Vintage Pharmaceuticals, LLC and Cornerstone BioPharma, Inc. (formerly known as Cornerstone Pharmaceuticals, Inc.) dated July 20, 2004 (Filed With SEC on November 5, 2008)
- Ex-10.4 First Amendment, dated July 1, 2008, to Copromotion Agreement between Atley Pharmaceuticals, Inc. and Cornerstone BioPharma, Inc. dated April 2, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.3 Copromotion Agreement between Atley Pharmaceuticals, Inc. and Cornerstone BioPharma, Inc. dated April 2, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.2 Change of Scope Agreement between Patheon, Inc. (formerly known as MOVA Pharmaceutical Corporation) and Cornerstone BioPharma, Inc. dated November 20, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.1 Agreement between Patheon, Inc. (formerly known as MOVA Pharmaceutical Corporation) and Cornerstone BioPharma, Inc. dated August 8, 2007 (Filed With SEC on November 5, 2008)
- Ex-10.55 Critical Therapeutics, Inc. Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 28, 2008)
- Ex-10.54 Critical Therapeutics, Inc. 2008 Salaries for Executive Officers (Filed With SEC on March 28, 2008)
- Ex-10.53 Critical Therapeutics, Inc. 2007 Cash Bonuses for Executive Officers (Filed With SEC on March 28, 2008)
- Ex-10.4 FFIS Co-Promotion Agreement (Filed With SEC on August 9, 2007)
- EX-10.3 Binding Letter Agreement relating to COPD Co-Promotion by and between the Registrant and Dey, L.P. dated March 13, 2007 (Filed With SEC on May 10, 2007)
- Ex-10.45 Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 16, 2007)
- Ex-10.44 2007 Salaries for Executive Officers (Filed With SEC on March 16, 2007)
- Ex-10.43 Cash Bonuses for Executive Officers (Filed With SEC on March 16, 2007)
- Ex-10.42 2007 Company Goals (Filed With SEC on March 16, 2007)
- 7,455,731 CRITICAL THERAPEUTICS, INC. PLACEMENT AGENT AGREEMENT (Filed With SEC on October 27, 2006)
- Ex-10.54 Maximum Annual Cash Bonuses for Executive Officers (Filed With SEC on March 7, 2006)
- Ex-10.53 Critical Therapeutics, Inc. 2006 Salaries for Executive Officers (Filed With SEC on March 7, 2006)
- Ex-10.52 Critical Therapeutics, Inc. 2005 Cash Bonuses for Executive Officers (Filed With SEC on March 7, 2006)
- Ex-10.51 Critical Therapeutics, Inc. 2006 Company Goals (Filed With SEC on March 7, 2006)
- Ex-10.20 Approval Agreement dated 3/7/06 with Kevin J. Tracey, MD (Filed With SEC on March 7, 2006)
- Ex-10.19 Approval Agreement dated 3/7/06 with H. Shaw Warren, Jr. MD (Filed With SEC on March 7, 2006)
- Ex-10.42 2005 Company Goals (Filed With SEC on March 17, 2005)
